Accession Number: | 0001209191-22-026890 |
Date: | 2022-04-30 |
Issuer: | NURIX THERAPEUTICS, INC. (NRIX) |
Original Submission Date: |
VAN HOUTE HANS
C/O NURIX THERAPEUTICS, INC.
1700 OWENS STREET, SUITE 205
SAN FRANCISCO, CA 94158
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-04-30 | M | 2,886 | a | $0.00 | 2,886 | direct | ||
COMMON STOCK | 2022-05-02 | S | 697 | d | $11.75 | 2,189 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2022-04-30 | deemed execution date | M | 2,886 (d) | common stock 2,886 | $0.00 | 43,291 | direct |
ID | footnote |
---|---|
f1 | the sales reported on this form 4 represent shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units ("rsus"). these sales are mandated by the issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the reporting person. |
f2 | each rsu represents a contingent right to receive one share of the issuer's common stock. |
f3 | the rsus will vest in substantially equal increments quarterly over four years, with the first quarterly increment vesting on april 30, 2022, subject to the reporting person's provision of services to the issuer on each vesting date. shares of the issuer's common stock will be delivered to the reporting person following vesting. |
f4 | rsus do not expire; they either vest or are canceled prior to the vest date. |